Researchers at the Ichilov Hospital in Tel Aviv report that out of 30 seriously ill Covid-patients that were treated with a cancer drug, 29 showed a significant improvement within two days and all were released within three to five days.

The drug is EXO-CD24 and it was originally developed to treat cancer patients. EXO-CD24 targets the  cytokine storm, a potentially lethal immune overreaction brought about by Covid-19 infections.